Sebastien Burel
No ORCID on file
· 1 paper in corpus
2025
Antisense oligonucleotides (ASOs) locally delivered to the central nervous system (CNS) are being approved as therapies for neurological diseases. After intrathecal injection of some ASOs, transient toxicities have been reported, but consid…